Breaking Down the Growing Women's Health Diagnostics Market projected size of $36.3 billion by 2030, CAGR of 6.9%
"Empowering Women's Health: Advances in Diagnostics Market on International Women's Day"
PORTLAND, OREGON, UNITED STATES, March 8, 2023 /EINPresswire.com/ -- ๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฐ๐จ๐ฆ๐๐ง'๐ฌ ๐ก๐๐๐ฅ๐ญ๐ก ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐ฏ๐๐ฅ๐ฎ๐๐ ๐๐ญ $19.2 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง 2020 ๐๐ง๐ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐๐ญ ๐ ๐๐๐๐ ๐จ๐ 6.9% ๐๐ซ๐จ๐ฆ 2021 ๐ญ๐จ 2030, ๐ซ๐๐๐๐ก๐ข๐ง๐ ๐ ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐ฌ๐ข๐ณ๐ ๐จ๐ $36.3 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ 2030. The global women's health diagnostics market has been growing steadily in recent years and is expected to continue to grow at a significant rate over the next decade. The increasing prevalence of various women's health conditions, such as breast cancer, cervical cancer, and osteoporosis, as well as the growing awareness of the importance of preventative health screening, are some of the key factors driving this growth. Additionally, advancements in medical technology and the development of new diagnostic tests are also contributing to the growth of the market.
In addition to diagnostic tests, women's health diagnostics also include preventative health screenings, such as routine gynecological exams and screenings for sexually transmitted infections (STIs).
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐๐ญ: https://www.alliedmarketresearch.com/request-sample/4521
Women's health diagnostics refer to medical tests and procedures that are specifically designed to diagnose and monitor conditions that affect women's health. These tests can include a variety of diagnostic methods, such as imaging tests, blood tests, and genetic testing, among others. Some examples of women's health diagnostic tests include mammograms, Pap tests, pelvic exams, breast MRI, ultrasound scans, and bone density tests. These tests are typically used to detect and monitor conditions such as breast cancer, ovarian cancer, cervical cancer, uterine fibroids, endometriosis, and osteoporosis.
๐๐ก๐ ๐จ๐ฏ๐๐ซ๐๐ฅ๐ฅ ๐ข๐ฆ๐ฉ๐๐๐ญ ๐จ๐ ๐๐๐๐๐-19 ๐ซ๐๐ฆ๐๐ข๐ง๐ฌ ๐ง๐๐ ๐๐ญ๐ข๐ฏ๐ ๐จ๐ง ๐ญ๐ก๐ ๐ฐ๐จ๐ฆ๐๐งโ๐ฌ ๐ก๐๐๐ฅ๐ญ๐ก ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ, ๐จ๐ฐ๐ข๐ง๐ ๐ญ๐จ ๐๐๐๐ฅ๐ข๐ง๐ ๐ข๐ง ๐ง๐ฎ๐ฆ๐๐๐ซ ๐จ๐ ๐ฉ๐๐ญ๐ข๐๐ง๐ญ ๐ฏ๐ข๐ฌ๐ข๐ญ๐ฌ ๐ข๐ง ๐ก๐จ๐ฌ๐ฉ๐ข๐ญ๐๐ฅ๐ฌ & ๐๐ฅ๐ข๐ง๐ข๐๐ฌ ๐๐จ๐ซ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ, ๐ญ๐ก๐ ๐ฌ๐ฎ๐ฌ๐ฉ๐๐ง๐ฌ๐ข๐จ๐ง ๐จ๐ ๐ง๐ฎ๐ฆ๐๐ซ๐จ๐ฎ๐ฌ ๐๐ฅ๐๐๐ญ๐ข๐ฏ๐ ๐ฉ๐ซ๐จ๐๐๐๐ฎ๐ซ๐๐ฌ ๐๐ง๐ ๐จ๐ฎ๐ญ๐ฉ๐๐ญ๐ข๐๐ง๐ญ ๐ฏ๐ข๐ฌ๐ข๐ญ๐ฌ, ๐ฐ๐ก๐ข๐๐ก ๐ซ๐๐๐ฎ๐๐๐ ๐ญ๐ก๐ ๐๐๐ฆ๐๐ง๐ ๐๐จ๐ซ ๐ฐ๐จ๐ฆ๐๐งโ๐ฌ ๐ก๐๐๐ฅ๐ญ๐ก ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐ ๐๐๐ฏ๐ข๐๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ.
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ
1. ABBOTT LABORATORIES
2. BECTON
3. DICKINSON AND COMPANY
4. CARDINAL HEALTH
5. F. HOFFMANN-LA ROCHE
6. GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)
7. HOLOGIC
8. KONINKLIJKE PHILIPS N.V.
9. QUEST DIAGNOSTICS
10. SIEMENS AKTIENGESELLSCHAFT
11. bioMรฉrieux SA
๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐: https://www.alliedmarketresearch.com/purchase-enquiry/4521
โ๐๐จ๐ฆ๐๐ง๐ฌ ๐๐๐๐ฅ๐ญ๐ก ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
The women's health diagnostics market can be segmented by type and end-user:
Type:
1. Accessories and Consumables: This segment includes products such as needles, catheters, biopsy forceps, and other consumables used in diagnostic procedures.
2. Diagnostic Tests:
โข Breast Cancer Testing: This segment includes tests such as hormone receptor tests, immunohistochemistry (IHC) tests, and other tests used to diagnose breast cancer.
โข Cervical Cancer Testing: This segment includes tests such as PAP smear (PAP) tests and HPV tests used to diagnose cervical cancer.
โข Prenatal Genetic Screening and Carrier Testing: This segment includes tests such as cystic fibrosis screening and other genetic tests used to screen for genetic disorders during pregnancy.
โข Pregnancy and Ovulation Testing: This segment includes lab-based and home-based pregnancy and ovulation testing kits.
โข Ovarian Cancer Testing: This segment includes tests used to diagnose ovarian cancer.
3. Diagnostic Devices:
โข Biopsy Devices: This segment includes devices such as core biopsy needles and vacuum-assisted biopsy devices used to obtain tissue samples for diagnostic purposes.
โข Imaging and Monitoring System: This segment includes imaging devices such as ultrasound devices, mammography systems, and other imaging and monitoring systems used to diagnose and monitor women's health conditions.
โข Ultrasound Devices: This segment includes OB and GYN ultrasound devices, breast ultrasound devices, and other ultrasound devices used for diagnostic purposes.
End-User:
1. Hospitals and Clinics: This segment includes hospitals and clinics where women receive diagnostic services.
2. Diagnostic and Imaging Centers: This segment includes specialized centers that provide diagnostic and imaging services for women.
3. Homecare: This segment includes home-based diagnostic services.
4. Others: This segment includes academic and research institutions and government organizations involved in women's health research and diagnostics.
๐๐ก๐ ๐ฐ๐จ๐ฆ๐๐ง'๐ฌ ๐ก๐๐๐ฅ๐ญ๐ก ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐๐๐ง ๐๐ฅ๐ฌ๐จ ๐๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐๐ฒ ๐ซ๐๐ ๐ข๐จ๐ง:
1. North America: This region includes the United States, Canada, and Mexico. The women's health diagnostics market in this region is expected to be driven by factors such as increasing awareness of women's health, rising prevalence of breast cancer and cervical cancer, and the presence of established healthcare infrastructure.
2. Europe: This region includes countries such as Germany, France, the United Kingdom, Italy, Spain, and the rest of Europe. The women's health diagnostics market in this region is expected to grow due to the increasing adoption of advanced diagnostic technologies, rising healthcare expenditure, and government initiatives to promote women's health.
3. Asia-Pacific: This region includes countries such as Japan, China, Australia, India, South Korea, and the rest of Asia-Pacific. The women's health diagnostics market in this region is expected to grow at a significant rate due to the increasing prevalence of women's health conditions, rising awareness of women's health, and the growing demand for advanced diagnostic technologies.
4. LAMEA: This region includes countries such as Brazil, Saudi Arabia, South Africa, and the rest of LAMEA. The women's health diagnostics market in this region is expected to grow due to the rising demand for diagnostic services, increasing prevalence of women's health conditions, and government initiatives to promote women's health.
๐๐ฎ๐ฒ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐จ๐ฆ๐๐ง๐ฌ ๐๐๐๐ฅ๐ญ๐ก ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ: https://www.alliedmarketresearch.com/checkout-final/8e5de87a7bd8b6af8af1db529691dbdb
๐ ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐?
What is the global market size of the women's health diagnostics market?
What factors are driving the growth of the women's health diagnostics market?
What are the different types of diagnostic tests and devices used in women's health diagnostics?
What are the major end-users of women's health diagnostics?
What are the major regions for women's health diagnostics market growth?
What are some of the challenges facing the women's health diagnostics market?
What are the emerging trends in women's health diagnostics?
What are some of the major players in the women's health diagnostics market?
What are the different regulatory frameworks governing women's health diagnostics?
How is the COVID-19 pandemic affecting the women's health diagnostics market?
David Correa
Allied Analytics LLP
+1-800-792-5285
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
